FDA: Insulet Omnipod DASH Recall Deemed Class I

 
• By Elizabeth Orr
  
FDA (Food and Drug Administration) sign at its headquarters in Washington
• Source: JHVEPhoto / Shutterstock.com
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Recalls

More from Policy & Regulation